Article
Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients
1 Dec 2019
Abstract excerpt
Background: Gallbladder cancer (GBC) is often diagnosed at an advanced stage with limited therapeutic options and poor prognosis. The five-year survival rate of this cancer when diagnosed at an advanced stage is below 5%, and the median survival time is less than a year with standard gemcitabine-based chemotherapy. Survival benefit with second-line treatment is unknown. Thus, there is an urgent need for novel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
